Personalised Cancer Screening Conference

On 8 October, the international conference “Personalised Cancer Screening – Lessons Learned and the Way Forward” took place at the University of Latvia in Riga.

Organised as part of the EUCanScreen Joint Action, the conference brought together leading European specialists – both from within the Joint Action and beyond the consortium – as well as participants from Taiwan, fostering international collaboration and the exchange of expertise.

Emerging Technologies

Throughout the day, participants explored topics such as the ethical and social implications of personalised screening, risk-based screening models for cervical, breast, colorectal, prostate, lung, and gastric cancers. Sessions also highlighted emerging technologies, including liquid biopsies, polygenic risk scores (PRS), and the role of artificial intelligence in screening.

Conclusions

The final plenary session addressed the importance of effective communication and citizen engagement in implementing personalised cancer screening programmes across healthcare systems.

The conference marks an important step towards personalised cancer prevention, which will help improve early diagnosis, reduce unnecessary examinations, and promote more efficient use of healthcare resources across Europe.